Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 197328, 6 pages
Conference Paper

Oncothermia Basic Research at In Vivo Level: The First Results in Japan

1Department of Veterinary Clinical Medicine, Faculty of Veterinary Science, Tottori University, 4-101 Koyama Minami, Tottori 680-8553, Japan
2“Frederic Joliot Curie” National Research Institute for Radiobiology and Radiohygiene, XXII. Ker. Anna u. 5, 1221 Budapest, Hungary
31st Department of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary
4Biotechnics Department, Faculty of Engineering, St. István University, Pater K. u. 1., 2100 Godollo, Hungary

Received 17 January 2013; Accepted 28 May 2013

Academic Editors: G. Baronzio, M. Jackson, and A. Szasz

This Conference Paper is based on a presentation given by G. Andocs at “Conference of the International Clinical Hyperthermia Society 2012” held from 12 October 2012 to 14 October 2012 in Budapest, Hungary.

Copyright © 2013 G. Andocs et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


This paper summarizes the first results of oncothermia basic research conducted in Tottori University, Japan, and had two parts. In the first part C26 murine colorectal cancer model was investigated and oncothermia treatment induced histomorphological and some molecular changes which were examined. In the second study 9L rat glioma model was used to investigate the oncothermia treatment effects on tumor tissue oxygenization. Results of these investigations are very important in oncothermia research because this was the first time when independent research laboratory has repeated oncothermia experiments and proved the significant antitumoral and beneficial effects of oncothermia treatment.

1. Background

Oncothermia method (OTM) is a long time (since 1989) applied method in oncology [1] with great clinical success [2]. Oncothermia research group conducts investigations to reveal the basic mechanism of action of this tumor treatment method in basic research level performing a huge number of in vivo studies. The tumor destruction efficacy and the role of temperature independent effects of the OTM were proven earlier and presented elsewhere [3, 4], as well as the recent in vivo results [5, 6]. In this paper we summarize the first results we have achieved in Tottori University, Japan.

2. Materials and Methods

2.1. Study I

In the first study we examine the effect of oncothermia treatment in a mouse tumor model.

2.1.1. Animal Model

Colon 26 (murine colorectal cancer) cell line derived allograft mouse tumor model was used for this study with double tumors (see Figure 1). The use of the mice and the procedures used in this study were approved by the Animal Research Committee of Tottori University.

Figure 1: Experimental mouse tumor model. Every animal had two tumors on the femoral regions, the right side was treated and the left side was individual control.
2.1.2. Experimental Setup and Treatment

A single shot 30 min oncothermia treatment was done reaching maximum 42°C intratumoral temperature, using the LabEHY system (Oncotherm Ltd.), under precise tumor temperature control using fluoroptic temperature measurement device (Lumasense m3300) (see Figure 2).

Figure 2: The experimental setup with the LabEHY system and a representative temperature measurement graph of the temperature curve of the tumors.
2.1.3. Study Design

Time course study was performed. After a single shot oncothermia treatment, animals were sacrificed at 6H, 24H, 72H, and 120H later and tumors were removed. There were 3 treated animals and 1 untreated control animal in all sampling group in every time point (see Figure 3).

Figure 3: Oncothermia treated experimental animals in this study.
2.1.4. Tumor Sample Processing

All the removed tumors were cut accurately at their centerline. After a standard histological process, the samples were stained with HE and TUNEL reaction and Ki-67 immunohistochemical (IHCH) detection were performed (HE staining and IHCH detection were performed by Sapporo Byori Kensa Center, Japan). Samples were evaluated using complex histomorphological methods. Besides the qualitative analysis, a quantitative microscopical evaluation was also performed in the tumor samples stained with Ki-67. In ten randomly chosen high magnification (400x) microscopic view area of the living part of the tumor tissue samples, the Ki-67 positive cell nuclei were counted, recorded, and evaluated.

2.2. Study II

In the second study we examined the effects of OTM to tumor oxygenization using a rat tumor model.

2.2.1. Animal Model

9L (rat glioma) cell line derived allograft rat tumor model was used. All animals had 2 tumors on both femoral regions. The use of the rats and the procedures used in this study were approved by the Animal Research Committee of Tottori University.

2.2.2. Oxygen Level Measurement

Tumor tissue oxygenization level was measured using an O2 sensitive electrode system (Eikon Kagaku Ltd. 150D model).

2.2.3. Study Design

In 11 rats, tumor tissue oxigenization level was measured using a pO2 sensitive electrode system right before the treatment. The sensor probe of the system was inserted into the tumor tissue with the help and guidance of a teflon catheter, and then the measured pO2 value was recorded. Then the probe and the catheter were removed and a single shot, 30min oncothermia treatment was performed using a LabEHY system (Oncotherm Ltd.), reaching maximum 42°C intratumoral temperature. Right after thetreatment the tumor oxigenization level was measured again (see Figure 4).

Figure 4: The study design. The 9L glioma cell line derived rat allograft tumor model (a), the oncothermia treatment procedure (b), and the tissue oxygenization measurement system (c).

3. Results

(i)Study I(a)Histomorphological Changes in a Qualitative and a Quantitative Way (see Figure 5).(b)Histomorphological Changes in Details (see Figure 6).(c)TUNEL Reaction (see Figure 7).(d)Ki-67 Expression Changes (see Figures 8 and 9).(ii)Study II(a)Results of the Tumor pO2 Level Measurement in a Rat Tumor Model (see Figure 10).

Figure 5: All the tumor samples involved in this study and the result graph of the quantitative analysis of the living/dead area ratio measurement. Drastic and selective tumor destruction was detected after a single shot oncothermia treatment. The tumor destruction was not immediate; it had a time delay. Samples marked with a red rectangle are evaluated in details.
Figure 6: Detailed morphological analysis of the tumor samples marked with red rectangle in Figure 5. 6 H after the treatment the tumor cells look intact, but 24 H after the treatment, the large part of the tumor is dead, and the cells are shrunk with picnotic cell nuclei. In the 48 H and 72 H samples definite late morphological signs of apoptotic cell death were observed: extremely high number of apoptotic bodies (marked with red arrow). 120 H after the treatment morphological signs of leukocyte (mostly neutrophils, marked with green arrow) invasion can be visible.
Figure 7: Result of the qualitative evaluation of TUNEL staining. TUNEL assay enzymatically labels the DNA fragments resulted by apoptotic cell death process. In the dead tumor area a huge number of TUNEL-positive cells were observed after a single shot OTM treatment.
Figure 8: Result of the qualitative evaluation of the Ki-67 staining. The Ki-67 proliferation marker protein is expressed in the nuclear membrane only in the dividing cells. That is why sampling for Ki-67 positive cell analysis and counting was done from the living part of the tumors. The high magnification images from the living part of the tumor samples (marked with red rectangle in the whole cross sections).
Figure 9: Result of the quantitative evaluation of the Ki-67 staining. Ki-67 positive cell nuclei were counted in 10 randomly chosen area of the living part of the tumor samples. In a very interesting way the number of Ki-67 positive cells was significantly decreased in the living part of the treated tumor compared to the control tumors.
Figure 10: Result of the tumor tissue oxygenization level measurement in each animal (a) and in average (b). Tumor tissue pO2 level was significantly higher right after the oncothermia treatment compared the pO2 level measured right before the treatment in case of 10 out of the total 11 animals. The pO2 level was almost double after the treatment in average.

4. Conclusions

(1)In the mouse study, oncothermia treatment can significantly destroy the tumor tissue in a large volume of the tumor even with single shot way. Oncothermia treatment induces apoptotic cell death in the destroyed tumor tissue and effectively inhibits cell proliferation in the living part of the tumor. (2)In the rat study, oncothermia treatment can significantly increase the tumor tissue oxygenization which creates the basis of the strong synergism with radiotherapy and some chemotherapy.


  1. A. Szasz, “Hyperthermia, a modality in the wings,” Journal of Cancer Research and Therapeutics, vol. 3, no. 1, pp. 56–66, 2007. View at Google Scholar · View at Scopus
  2. A. Szasz, N. Szasz, and O. Szasz, Oncothermia. Principles and Practices, Springer, Dordrecht, The Netherlands, 2010,
  3. G. Andocs, O. Szasz, and A. Szasz, “Oncothermia treatment of cancer: from the laboratory to clinic,” Electromagnetic Biology and Medicine, vol. 28, no. 2, pp. 148–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Andocs, H. Renner, L. Balogh, L. Fonyad, C. Jakab, and A. Szasz, “Strong synergy of heat and modulated electromagnetic field in tumor cell killing,” Strahlentherapie und Onkologie, vol. 185, no. 2, pp. 120–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Meggyeshazi, “Programmed cell death induced by modulated electro-yperthermia,” in Proceedings of International Clinical Hyperthermia Society (ICHS '12), 2012.
  6. N. Meggyeshazi, “Early changes in protein expression releated to modulated electro-hyperthermia,” in Proceedings of International Clinical Hyperthermia Society (ICHS '12), 2012.